1217598-28-1 Usage
Description
(R)-1-Benzyl 2-Methyl piperazine-1,2-dicarboxylate is a heterocyclic organic compound belonging to the piperazine derivative class. It is recognized as a pharmaceutical intermediate with a unique chemical structure that allows it to interact with various biological targets in the body. (R)-1-Benzyl 2-Methyl piperazine-1,2-dicarboxylate has garnered interest for its potential role in treating central nervous system disorders and is utilized in the synthesis of specific drugs, positioning it as a valuable asset in drug development within the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
(R)-1-Benzyl 2-Methyl piperazine-1,2-dicarboxylate is used as a pharmaceutical intermediate for its ability to be a building block in the development of new drugs. Its interaction with biological targets makes it a promising candidate for further research and development.
Used in the Treatment of Central Nervous System Disorders:
In the medical field, (R)-1-Benzyl 2-Methyl piperazine-1,2-dicarboxylate is used as a potential therapeutic agent for various central nervous system disorders, capitalizing on its capacity to engage with specific biological targets to elicit desired pharmacological effects.
Used in Drug Synthesis:
(R)-1-Benzyl 2-Methyl piperazine-1,2-dicarboxylate is also utilized as a key component in the synthesis of certain drugs, contributing to the creation of novel medicinal agents that address unmet clinical needs.
Check Digit Verification of cas no
The CAS Registry Mumber 1217598-28-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,5,9 and 8 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1217598-28:
(9*1)+(8*2)+(7*1)+(6*7)+(5*5)+(4*9)+(3*8)+(2*2)+(1*8)=171
171 % 10 = 1
So 1217598-28-1 is a valid CAS Registry Number.
1217598-28-1Relevant articles and documents
SPIRO CYCLOPENTANE COMPOUNDS USEFUL AS ANTAGONISTS OF THE H1-RECEPTOR
-
Page/Page column 50, (2009/03/07)
This invention relates to novel spiro cyclopentane derivatives of formula (I) or a pharmaceutically acceptable salt thereof, for treating diseases and conditions of the central nervous system (CNS), in particular sleep disorders.
Synthesis, resolution, and absolute configuration of novel tricyclic benzodiazepines
Matthews, Jay M.,Dyatkin, Alexey B.,Evangelisto, Mary,Gauthier, Diane A.,Hecker, Leonard R.,Hoekstra, William J.,Liu, Fuqiang,Poulter, Brenda L.,Sorgi, Kirk L.,Maryanoff, Bruce E.
, p. 1259 - 1267 (2007/10/03)
The synthesis, resolution, and stereochemical characterization of novel piperazino-, thiazino-, and oxazinobenzodiazepines are described. The absolute stereochemistry of the heterotricycles was determined by using X-ray crystallography and the enantiomeri
